Welcome to our dedicated page for Olaplex Holdings SEC filings (Ticker: OLPX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to U.S. Securities and Exchange Commission filings for Olaplex Holdings, Inc. (NASDAQ: OLPX), a science-enabled, technology-driven beauty company focused on hair health and bond-building formulations. Through these filings, investors can review how Olaplex reports on its operations, financial condition and key risks as a manufacturer in the toilet preparation and broader health and beauty space.
Olaplex’s SEC submissions include annual reports on Form 10-K, which typically contain detailed discussions of its omnichannel business model spanning professional, specialty retail and direct-to-consumer channels, as well as risk factors such as competition in the beauty industry, brand perception, international operations and indebtedness. Quarterly reports on Form 10-Q provide interim financial statements and management’s discussion of recent performance, including net sales trends and the use of non-GAAP measures like adjusted EBITDA and adjusted gross profit, as described in the company’s earnings releases.
The company also files current reports on Form 8-K to disclose material events. Recent 8-K filings have covered quarterly results and the stock purchase agreement through which a subsidiary acquired Purvala Bioscience, a biotech company developing bioinspired technologies for health and beauty applications, as well as board appointments. For those monitoring insider activity, Form 4 filings (when available) report changes in beneficial ownership by directors, officers and other insiders.
On Stock Titan, these documents are updated in near real time as they are posted to EDGAR. AI-powered summaries help explain lengthy sections of 10-K and 10-Q filings, highlight key items in 8-K disclosures, and make it easier to understand topics like non-GAAP reconciliations, risk factors and significant agreements. This allows users to quickly navigate Olaplex’s regulatory history, from its bond-focused haircare strategy to corporate transactions and governance developments, without reading every page of each filing.
Olaplex Holdings insider grant of restricted stock units to a director. Director Jerome Griffith was granted 110,294 restricted stock units (RSUs) of Olaplex common stock on 08/12/2025 at no cash price. Each RSU represents a conditional right to one share and the award will vest in full on the date of the company’s 2026 Annual Meeting of Stockholders, subject to continued service. After the grant, the reporting person beneficially owns 110,294 shares on a direct basis related to these RSUs. The filing states the award was made under the Issuer’s 2021 Equity Incentive Plan.
Olaplex Holdings director Deirdre Findlay was granted 110,294 restricted stock units (RSUs) under the company's 2021 Equity Incentive Plan, reported on Form 4. Each RSU represents the conditional right to one share of common stock and was recorded as an acquisition on 08/12/2025 at no cash price. The RSUs will vest in full on the date of Olaplex's 2026 Annual Meeting of Stockholders, contingent on the reporting person's continued service through the vesting date. The filing was signed by an attorney-in-fact on 08/14/2025 and includes a Power of Attorney exhibit.
Olaplex Holdings director Pamela J. Edwards received a grant of 110,294 restricted stock units (RSUs) on 08/12/2025. Each RSU represents the conditional right to one share of Olaplex common stock and was reported as issued at a $0 price. The RSUs are scheduled to vest in full on the date of the Issuer's 2026 Annual Meeting of Stockholders, subject to Ms. Edwards' continued service through that vesting date. Following the reported transaction, the reporting person beneficially owns 110,294 shares directly. The form was submitted via attorney-in-fact signature on 08/14/2025.
John P. Bilbrey, a director of Olaplex Holdings, Inc. (OLPX), received a grant of 294,118 restricted stock units (RSUs) on 08/12/2025. Each RSU converts into one share of common stock and the grant was recorded as an acquisition at $0 per RSU. After the grant, Mr. Bilbrey beneficially owns 640,021 shares in total, of which 318,418 shares are held indirectly through the Amended and Restated John P. Bilbrey Revocable Declaration of Trust. The RSUs vest in full on the date of Olaplex's 2026 Annual Meeting of Stockholders, conditional on his continued service through that date. The Form 4 was signed by an attorney-in-fact on 08/14/2025.
Olaplex Holdings, Inc. (OLPX) filed a Form 144 reporting a proposed sale of 108,335 common shares through Morgan Stanley Smith Barney LLC, scheduled approximately 08/14/2025 on NASDAQ. The filing states these shares were acquired as restricted stock units on 08/13/2025 and were paid as compensation; the aggregate market value is $158,167.16 and the issuer’s shares outstanding are listed as 667,081,086, so the sale represents about 0.016% of outstanding stock. No securities were reported sold by the filer in the past three months. The filer affirms they are not aware of any undisclosed material adverse information.
Olaplex (NASDAQ: OLPX) filed a routine Form 4 on June 29, 2025. The filing states that former director Paula Zusi ceased serving on the board effective June 10, 2025 and is therefore no longer subject to Section 16 reporting requirements. No purchases, sales, or other equity transactions were disclosed, and the tables for both non-derivative and derivative securities list no entries. The document is filed voluntarily to formally register Ms. Zusi’s change in reporting status.
Because the Form 4 reports no share transactions or monetary amounts, it represents an administrative update rather than a market-moving event.